Renaud Heine

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study

Laura A. Hatfield, V. Novack, L. Lix, 2022, BMJ.

Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma.

F. Thielen, Renaud Heine, C. D. Groot, 2022, Cytotherapy.

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future

M. Kersten, U. Jaeger, H. Einsele, 2021, HemaSphere.